博晖创新：12月1日召开董事会会议

Group 1 - The core point of the article is that Bohui Innovation (SZ 300318) held a temporary board meeting on December 1, 2025, to discuss the election of a new audit committee member and other related documents [1] - For the first half of 2025, Bohui Innovation's revenue composition was 71.68% from blood products and 28.32% from in vitro diagnostics [1] - As of the time of reporting, Bohui Innovation's market capitalization was 5.8 billion yuan [1]